Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

doi:10.1093/cid/ciw444

. 2016 Aug 15;63(4):433-42.

doi: 10.1093/cid/ciw444.

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Thomas F Patterson¹, George R Thompson 3rd², David W Denning³, Jay A Fishman⁴, Susan Hadley⁵, Raoul Herbrecht⁶, Dimitrios P Kontoyiannis⁷, Kieren A Marr⁸, Vicki A Morrison⁹, M Hong Nguyen¹⁰, Brahm H Segal¹¹, William J Steinbach¹², David A Stevens¹³, Thomas J Walsh¹⁴, John R Wingard¹⁵, Jo-Anne H Young¹⁶, John E Bennett¹⁷

Affiliations

¹ University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System.
² University of California, Davis.
³ National Aspergillosis Centre, University Hospital of South Manchester, University of Manchester, United Kingdom.
⁴ Massachusetts General Hospital and Harvard Medical School.
⁵ Tufts Medical Center, Boston, Massachusetts.
⁶ University of Strasbourg, France.
⁷ University of Texas MD Anderson Cancer Center, Houston.
⁸ Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
⁹ Hennepin County Medical Center and University of Minnesota, Minneapolis.
¹⁰ University of Pittsburgh, Pennsylvania.
¹¹ University at Buffalo Jacobs School of Medicine and Biomedical Sciences, and Roswell Park Cancer Institute, New York.
¹² Duke University Medical Center, Durham, North Carolina.
¹³ California Institute for Medical Research, San Jose.
¹⁴ New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.
¹⁵ University of Florida, Gainesville.
¹⁶ University of Minnesota, Minneapolis.
¹⁷ Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.

PMID: 27481947
PMCID: PMC4967611
DOI: 10.1093/cid/ciw444

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Thomas F Patterson et al. Clin Infect Dis. 2016.

. 2016 Aug 15;63(4):433-42.

doi: 10.1093/cid/ciw444.

Authors

Affiliations

¹ University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System.
² University of California, Davis.
³ National Aspergillosis Centre, University Hospital of South Manchester, University of Manchester, United Kingdom.
⁴ Massachusetts General Hospital and Harvard Medical School.
⁵ Tufts Medical Center, Boston, Massachusetts.
⁶ University of Strasbourg, France.
⁷ University of Texas MD Anderson Cancer Center, Houston.
⁸ Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
⁹ Hennepin County Medical Center and University of Minnesota, Minneapolis.
¹⁰ University of Pittsburgh, Pennsylvania.
¹¹ University at Buffalo Jacobs School of Medicine and Biomedical Sciences, and Roswell Park Cancer Institute, New York.
¹² Duke University Medical Center, Durham, North Carolina.
¹³ California Institute for Medical Research, San Jose.
¹⁴ New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.
¹⁵ University of Florida, Gainesville.
¹⁶ University of Minnesota, Minneapolis.
¹⁷ Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.

PMID: 27481947
PMCID: PMC4967611
DOI: 10.1093/cid/ciw444

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Keywords: allergic aspergillosis; amphotericin; aspergillosis; azoles; chronic aspergillosis; echniocandins; fungal diagnostics; invasive aspergillosis.

Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

PubMed Disclaimer

Figures

**Figure 1.**
Approach and implications to rating the quality of evidence and strength of recommendations using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology (unrestricted use of the figure granted by the US GRADE Network) [1].

See this image and copyright information in PMC

Cited by

Understanding the clinical and environmental drivers of antifungal resistance in the One Health context.
Williams CC, Gregory JB, Usher J. Williams CC, et al. Microbiology (Reading). 2024 Oct;170(10):001512. doi: 10.1099/mic.0.001512. Microbiology (Reading). 2024. PMID: 39475703 Free PMC article. Review.
Invasive fungal infections in non-neutropenic patients.
Kreitmann L, Blot S, Nseir S. Kreitmann L, et al. Intensive Care Med. 2024 Dec;50(12):2166-2170. doi: 10.1007/s00134-024-07683-2. Epub 2024 Oct 21. Intensive Care Med. 2024. PMID: 39432102 No abstract available.
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits.
Wang S, Li C, Dong Y, Dong W. Wang S, et al. Eur J Clin Pharmacol. 2024 Dec;80(12):1845-1855. doi: 10.1007/s00228-024-03756-9. Epub 2024 Sep 9. Eur J Clin Pharmacol. 2024. PMID: 39249114 Review.
IL-17 in plasma and bronchoalveolar lavage fluid in non-neutropenic patients with invasive pulmonary aspergillosis.
He Q, Cao J, Zhang M, Feng C. He Q, et al. Front Cell Infect Microbiol. 2024 Aug 8;14:1402888. doi: 10.3389/fcimb.2024.1402888. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39176263 Free PMC article.
Fungal infections in immunocompromised critically ill patients.
Garnacho-Montero J, Barrero-García I, León-Moya C. Garnacho-Montero J, et al. J Intensive Med. 2024 Mar 16;4(3):299-306. doi: 10.1016/j.jointm.2024.01.005. eCollection 2024 Jul. J Intensive Med. 2024. PMID: 39035612 Free PMC article. Review.

See all "Cited by" articles

References

1. US GRADE Network. Approach and implications to rating the quality of evidence and strength of recommendations using the GRADE methodology. Available at: http://www.gradeworkinggroup.org/ Accessed 1 April 2016.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] US GRADE Network. Approach and implications to rating the quality of evidence and strength of recommendations using the GRADE methodology. Available at: http://www.gradeworkinggroup.org/ Accessed 1 April 2016.

[2] US GRADE Network. Approach and implications to rating the quality of evidence and strength of recommendations using the GRADE methodology. Available at: http://www.gradeworkinggroup.org/ Accessed 1 April 2016.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Affiliations

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Authors

Affiliations

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical